Seaside Therapeutics Named a “Fierce 15” Biotech Company for 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seaside Therapeutics, Inc. announced today that the editors of FierceBiotech have selected the Company as one of the Fierce 15 for 2012, designating it as one of the most promising private companies in the biotechnology industry. Every year FierceBiotech evaluates hundreds of private companies for its annual Fierce 15 list, which is based on a variety of factors such as the strength of its technology, partnerships, venture backers and a competitive market position.